Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks

PHASE2CompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Rheumatoid Arthritis
Interventions
DRUG

CP-690,550

Oral tablets administered at a dose of 5 mg BID for 6 weeks

DRUG

CP-690,550

Oral tablets administered at a dose of 15 mg BID for 6 weeks

DRUG

CP-690,550

30 mg BID for 6 weeks

OTHER

Placebo

Placebo tablets

Trial Locations (60)

9000

Pfizer Investigational Site, Ghent

10098

Pfizer Investigational Site, Berlin

11803

Pfizer Investigational Site, Plainview

14000

Pfizer Investigational Site, Tlalpan Seccion 16

15706

Pfizer Investigational Site, Santiago de Compostela

15904

Pfizer Investigational Site, Johnstown

16132

Pfizer Investigational Site, Genova

16635

Pfizer Investigational Site, Ducansville

17033

Pfizer Investigational Site, Neubrandenburg

19002

Pfizer Investigational Site, Guadalajara

20230

Pfizer Investigational Site, Aguascalientes

22081

Pfizer Investigational Site, Hamburg

27100

Pfizer Investigational Site, Pavia

28046

Pfizer Investigational Site, Madrid

28210

Pfizer Investigational Site, Charlotte

28601

Pfizer Investigational Site, Hickory

28602

Pfizer Investigational Site, Hickory

29204

Pfizer Investigational Site, Columbia

29406

Pfizer Investigational Site, Charleston

31134

Pfizer Investigational Site, Hildesheim

32804

Pfizer Investigational Site, Orlando

33173

Pfizer Investigational Site, Miami

33614

Pfizer Investigational Site, Tampa

33765

Pfizer Investigational Site, Clearwater

34652

Pfizer Investigational Site, New Port Richey

34668

Pfizer Investigational Site, Port Richey

37203

Pfizer Investigational Site, Nashville

41014

Pfizer Investigational Site, Seville

44690

Pfizer Investigational Site, Guadalajara

45402

Pfizer Investigational Site, Dayton

50139

Pfizer Investigational Site, Florence

52002

Pfizer Investigational Site, Dubuque

65191

Pfizer Investigational Site, Wiesbaden

78240

Pfizer Investigational Site, San Luis Potosí City

80639

Pfizer Investigational Site, München

91786

Pfizer Investigational Site, Upland

98201

Pfizer Investigational Site, Everett

98405

Pfizer Investigational Site, Tacoma

34474-7455

Pfizer Investigational Site, Ocala

52001-7313

Pfizer Investigational Site, Dubuque

03301

Pfizer Investigational Site, Concord

75231-4496

Pfizer Investigational Site, Dallas

74043-110

Pfizer Investigational Site, Goiânia

74110-120

Pfizer Investigational Site, Goiânia

80060-240

Pfizer Investigational Site, Curitiba

04230-000

Pfizer Investigational Site, São Paulo

05001-000

Pfizer Investigational Site, São Paulo

T5M 0H4

Pfizer Investigational Site, Edmonton

V8P 5P6

Pfizer Investigational Site, Victoria

A1C 5B8

Pfizer Investigational Site, St. John's

N6A 4V2

Pfizer Investigational Site, London

M5T 2S8

Pfizer Investigational Site, Toronto

01067

Pfizer Investigational Site, Dresden

04103

Pfizer Investigational Site, Leipzig

06726

Pfizer Investigational Site, México

040 11

Pfizer Investigational Site, Košice

921 01

Pfizer Investigational Site, Piešťany

012 07

Pfizer Investigational Site, Žilina

08003

Pfizer Investigational Site, Barcelona

08907

Pfizer Investigational Site, L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY